Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950103-20-011713
Filing Date
2020-06-15
Accepted
2020-06-15 21:20:21
Documents
2
Period of Report
2020-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 dp130269_3-lloyd.html 3  
1 FORM 3 dp130269_3-lloyd.xml 3 11174
2 EXHIBIT 24 dp130269_ex24.htm EX-24 7102
  Complete submission text file 0000950103-20-011713.txt   19613
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Issuer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ROYALTY PHARMA PLC 110 EAST 59TH STREET NEW YORK NY 10022
Business Address
Lloyd George W. (Reporting) CIK: 0001814899 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39329 | Film No.: 20964811